Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation. - Sagie S; Babu T; Weller C; Tabachnik C; Livneh I; Quast NP; Gumpert N; Shomuradova A; Raybould MI; Levy R; Malko D; Alfia A; et al. (Cell reports. Medicine, 2025)